Roche's Avastin Fights Early Breast Cancer in 2 Studies: Will it be Re-approved?

Is Avastin back in the fold for breast cancer? The FDA revoked Avastin's approval for treating breast cancer in November, 2011, saying the drug didn't extend life and could cause dangerous side effects. But two new studies released this week showed the drug made tumors disappear in women with early stages of breast cancer. The studies' surprising results may reopen the debate about the value of Avastin for breast cancer. These were the first big tests of the drug for early breast cancer, and doctors were cautiously excited that it showed potential.